A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Universität des Saarlandes
University of Wisconsin, Madison
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AIDS Malignancy Consortium